CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.

PBMs like CVS Caremark negotiate drug prices on behalf of health plans and often receive manufacturer rebates in return for formulary placements of ... Wegovy and Zepbound — effective July 1.

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients. By Rebecca Robbins ...

CVS Caremark has been ordered to pay $95 million after a federal judge found the pharmacy benefit manager improperly inflated Medicare Part D drug prices by failing to report required pharmacy ...

A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for ...

The U.S. secured a partial judgment in its favor on claims that CVS’s pharmacy benefit management subsidiary, Caremark, ...

In 2008, CVS Caremark, a prescription benefit management company, signed on to use Microsoft's HealthVault. ... Lilly hit as PBM drops Zepbound, but retains Wegovy.

The shares closed down nearly 12% after CVS Health's revelation and Lilly's announcement that, despite a 45% surge in first-quarter revenues driven by Zepbound (tirzepatide) and diabetes ...